Glaxosmithkline Capital Inc: 8-A12B filed Sep 15, 2026

Form type

8-A12B

Filing date

Sep 15, 2026

Accession number

0001193125-26-391619

Filer

Glaxosmithkline Capital Inc (CIK 1224462)